All Curated Mutation Sites in HPV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
E1
  
E1^E4
  
E2
  
E5
  
E6
  
E7
  
L1
  
L2
  

Keyword: Uterine Cervical Neoplasms-24368255
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 24368255 C632T
E7
E7
Uterine Cervical Neoplasms
G
R
S
L
View
2 24368255 G41R
E7
E7
Uterine Cervical Neoplasms
G
R
S
L
View
3 24368255 G599A
E7
E7
Uterine Cervical Neoplasms
G
R
S
L
View
4 24368255 G63D
E7
E7
Uterine Cervical Neoplasms
G
R
S
L
View
5 24368255 G63S
E7
E7
Uterine Cervical Neoplasms
G
R
S
L
View
6 24368255 G694A
E7
E7
Uterine Cervical Neoplasms
G
R
S
L
View
7 24368255 G760A
E7
E7
Uterine Cervical Neoplasms
G
R
S
L
View
8 24368255 G761A
E7
E7
Uterine Cervical Neoplasms
G
R
S
L
View
9 24368255 R9K
E7
E7
Uterine Cervical Neoplasms
G
R
S
L
View
10 24368255 T20I
E7
E7
Uterine Cervical Neoplasms
G
R
S
L
View
11 24368255 T726C
E7
E7
Uterine Cervical Neoplasms
G
R
S
L
View
12 24368255 T744G
E7
E7
Uterine Cervical Neoplasms
G
R
S
L
View
13 24368255 T803C
E7
E7
Uterine Cervical Neoplasms
G
R
S
L
View
14 24368255 V77A
E7
E7
Uterine Cervical Neoplasms
G
R
S
L
View
15 24368255 A260C
E6
E6
Uterine Cervical Neoplasms
G
R
S
L
View
16 24368255 A388C
E6
E6
Uterine Cervical Neoplasms
G
R
S
L
View
17 24368255 C187T
E6
E6
Uterine Cervical Neoplasms
G
R
S
L
View
18 24368255 C307T
E6
E6
Uterine Cervical Neoplasms
G
R
S
L
View
19 24368255 K93N
E6
E6
Uterine Cervical Neoplasms
G
R
S
L
View
Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.